Advertisement
Advances in Clinical Radiology

Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation and the Management of Portal Vein Thrombosis

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Clinical Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Salem R.
        • Vouche M.
        • Baker T.
        • et al.
        Pretransplant portal vein recanalization—transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis.
        Transplantation. 2015; 99: 2347-2355
        • Knight G.M.
        • Clark J.
        • Boike J.R.
        • et al.
        TIPS for adults without cirrhosis with chronic mesenteric venous thrombosis and EHPVO refractory to standard-of-care therapy.
        Hepatology. 2021; 74: 2735-2744
        • Al Ghumlas A.K.
        • Abdel Gader A.G.M.
        • Al Faleh F.Z.
        Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests?.
        Blood Coagul Fibrinolysis. 2005; 16: 329-335
        • Kelly D.
        • Summerfield J.
        Hemostasis in liver disease.
        Semin Liver Dis. 1987; 7: 182-191
        • Mammen E.F.
        Coagulation defects in liver disease.
        Med Clin North Am. 1994; 78: 545-554
        • Francoz C.
        • Belghiti J.
        • Vilgrain V.
        • et al.
        Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.
        Gut. 2005; 54: 691-697
        • Okuda K.
        • Ohnishi K.
        • Kimura K.
        • et al.
        Incidence of portal vein thrombosis in liver cirrhosis.
        Gastroenterology. 1985; 89: 279-286
        • Tripodi A.
        • Anstee Q.M.
        • Sogaard K.K.
        • et al.
        Hypercoagulability in cirrhosis: causes and consequences.
        J Thromb Haemost. 2011; 9: 1713-1723
        • Yamashita Y-i
        • Bekki Y.
        • Imai D.
        • et al.
        Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer.
        Thromb Res. 2014; 134: 826-831
        • Amitrano L.
        • Anna Guardascione M.
        • Brancaccio V.
        • et al.
        Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
        J Hepatol. 2004; 40: 736-741
        • Charco R.
        • Fuster J.
        • Fondevila C.
        • et al.
        Portal vein thrombosis in liver transplantation.
        Transplant Proc. 2005; 37: 3904-3905
        • Nonami T.
        • Yokoyama I.
        • Iwatsuki S.
        • et al.
        The incidence of portal vein thrombosis at liver transplantation.
        Hepatology. 1992; 16: 1195-1198
        • Bagheri Lankarani K.
        • Homayon K.
        • Motevalli D.
        • et al.
        Risk factors for portal vein thrombosis in patients with cirrhosis awaiting liver transplantation in Shiraz, Iran.
        Hepat Mon. 2015; 15: e26407
        • Bianchini M.
        • De Pietri L.
        • Villa E.
        Coagulopathy in liver diseases: complication or therapy?.
        Dig Dis. 2014; 32: 609-614
        • Decalonne L.
        • d’Alteroche L.
        • Perarnau J.-M.
        • et al.
        Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis.
        Thromb Haemost. 2010; 104: 741-749
        • Tripodi A.
        • Primignani M.
        • Chantarangkul V.
        • et al.
        An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.
        Gastroenterology. 2009; 137: 2105-2111
        • Tripodi A.
        • Primignani M.
        • Lemma L.
        • et al.
        Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis.
        J Hepatol. 2013; 59: 265-270
        • Stine J.G.
        • Wang J.
        • Shah P.M.
        • et al.
        Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study.
        Liver Int. 2017; 38: 94-101
        • Zocco M.A.
        • Di Stasio E.
        • De Cristofaro R.
        • et al.
        Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
        J Hepatol. 2009; 51: 682-689
        • Moreno A.H.
        • Burchell A.R.
        • Rousselot L.M.
        • et al.
        Portal blood flow in cirrhosis of the liver.
        J Clin Invest. 1967; 46: 436-445
        • Mehta G.
        • Gustot T.
        • Mookerjee R.P.
        • et al.
        Inflammation and portal hypertension: the undiscovered country.
        J Hepatol. 2014; 61: 155-163
        • Violi F.
        • Ferro D.
        • Basili S.
        • et al.
        Ongoing prothrombotic state in the portal circulation of cirrhotic patients.
        Thromb Haemost. 1997; 77: 044-047
        • Connolly G.C.
        • Chen R.
        • Hyrien O.
        • et al.
        Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.
        Thromb Res. 2008; 122: 299-306
        • Yerdel M.A.
        • Gunson B.
        • Mirza D.
        • et al.
        Portal vein thrombosis in adults undergoing liver transplantation.
        Transplantation. 2000; 69: 1873-1881
        • Denninger M.-H.
        • Chaït Y.
        • Casadevall N.
        • et al.
        Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors.
        Hepatology. 2000; 31: 587-591
        • Janssen H.L.A.
        • Meinardi J.
        • Vleggaar F.P.
        • et al.
        Factor V Leiden mutation, prothrombin gene mutation and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis.
        Eur J Gastroenterol Hepatol. 1998; 10: A69
        • Primignani M.
        • Martinelli I.
        • Bucciarelli P.
        • et al.
        Risk factors for thrombophilia in extrahepatic portal vein obstruction.
        Hepatology. 2005; 41: 603-608
        • Valla D.
        • Casadevall N.
        • Huisse M.G.
        • et al.
        Etiology of portal vein thrombosis in adults.
        Gastroenterology. 1988; 94: 1063-1069
        • Hoekstra J.
        • Bresser E.L.
        • Smalberg J.H.
        • et al.
        Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms.
        J Thromb Haemost. 2011; 9: 2208-2214
        • Kiladjian J.-J.
        • Cervantes F.
        • Leebeek F.W.G.
        • et al.
        The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.
        Blood. 2008; 111: 4922-4929
        • Qi X.
        • Yang Z.
        • Bai M.
        • et al.
        Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis.
        Aliment Pharmacol Ther. 2011; 33: 1087-1103
        • Qi X.
        • Zhang C.
        • Han G.
        • et al.
        Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.
        J Gastroenterol Hepatol. 2012; 27: 1036-1043
        • Qi X.
        • De Stefano V.
        • Wang J.
        • et al.
        Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies.
        J Gastroenterol Hepatol. 2013; 28: 432-442
        • Plessier A.
        • Darwish-Murad S.
        • Hernandez-Guerra M.
        • et al.
        Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study.
        Hepatology. 2009; 51: 210-218
      1. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
        Chest. 2012; 142: 1698-1704
      2. EASL Clinical Practice Guidelines: Vascular diseases of the liver.
        J Hepatol. 2016; 64: 179-202
        • Ageno W.
        • Beyer-Westendorf J.
        • Garcia D.A.
        • et al.
        Guidance for the management of venous thrombosis in unusual sites.
        J Thromb Thrombolysis. 2016; 41: 129-143
        • DeLeve L.D.
        • Valla D.-C.
        • Garcia-Tsao G.
        American Association for the Study Liver D. Vascular disorders of the liver.
        Hepatology (Baltimore, Md). 2009; 49: 1729-1764
        • Intagliata N.M.
        • Argo C.K.
        • Stine J.G.
        • et al.
        Concepts and controversies in haemostasis and thrombosis associated with liver disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.
        Thromb Haemost. 2018; 118: 1491-1506
        • Tait C.
        • Baglin T.
        • Watson H.
        • et al.
        Guidelines on the investigation and management of venous thrombosis at unusual sites.
        Br J Haematol. 2012; 159: 28-38
        • Wu M.
        • Schuster M.
        • Tadros M.
        Update on management of portal vein thrombosis and the role of novel anticoagulants.
        J Clin translational Hepatol. 2019; 7: 154-164
        • Mantaka A.
        • Augoustaki A.
        • Kouroumalis E.A.
        • et al.
        Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.
        Ann Gastroenterol. 2018; 31: 315-329
        • Loffredo L.
        • Pastori D.
        • Farcomeni A.
        • et al.
        Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis.
        Gastroenterology. 2017; 153: 480-487.e1
        • Delgado M.G.
        • Seijo S.
        • Yepes I.
        • et al.
        Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
        Clin Gastroenterol Hepatol. 2012; 10: 776-783
        • Chen H.
        • Turon F.
        • Hernández-Gea V.
        • et al.
        Nontumoral portal vein thrombosis in patients awaiting liver transplantation.
        Liver Transplant. 2016; 22: 352-365
        • Northup P.G.
        • Sundaram V.
        • Fallon M.B.
        • et al.
        Hypercoagulation and thrombophilia in liver disease.
        J Thromb Haemost. 2007; (070924041816002)https://doi.org/10.1111/j.1538-7836.2007.02772.x
        • Khoury T.
        • Ayman A.R.
        • Cohen J.
        • et al.
        The complex role of anticoagulation in cirrhosis: an updated review of where we are and where we are going.
        Digestion. 2016; 93: 149-159
        • Grisham A.
        • Lohr J.
        • Guenther J.M.
        • et al.
        Deciphering mesenteric venous thrombosis: imaging and treatment.
        Vasc Endovascular Surg. 2005; 39: 473-479
        • Maldonado T.S.
        • Blumberg S.N.
        • Sheth S.U.
        • et al.
        Mesenteric vein thrombosis can be safely treated with anticoagulation but is associated with significant sequelae of portal hypertension.
        J Vasc Surg Venous Lymphatic Disord. 2016; 4: 400-406
        • Morasch M.D.
        • Ebaugh J.L.
        • Chiou A.C.
        • et al.
        Mesenteric venous thrombosis: a changing clinical entity.
        J Vasc Surg. 2001; 34: 680-684
        • Acosta S.
        • Alhadad A.
        • Svensson P.
        • et al.
        Epidemiology, risk and prognostic factors in mesenteric venous thrombosis.
        Br J Surg. 2008; 95: 1245-1251
        • Clavien P.A.
        Diagnosis and management of mesenteric infarction.
        Br J Surg. 1990; 77: 601-603
        • Kumar S.
        • Sarr M.G.
        • Kamath P.S.
        Mesenteric venous thrombosis.
        N Engl J Med. 2001; 345: 1683-1688
        • Kumar S.
        • Kamath P.S.
        Acute superior mesenteric venous thrombosis: one disease or two?.
        Am J Gastroenterol. 2003; 98: 1299-1304
        • Lendoire J.
        • Raffin G.
        • Cejas N.
        • et al.
        Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome.
        HPB (Oxford). 2007; 9: 352-356
        • Lladó L.
        • Fabregat J.
        • Castellote J.
        • et al.
        Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality.
        Clin Transplant. 2007; https://doi.org/10.1111/j.1399-0012.2007.00728.x
        • Pan C.
        • Shi Y.
        • Zhang J.J.
        • et al.
        Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China.
        Transplant Proc. 2009; 41: 3761-3765
        • Englesbe M.J.
        • Schaubel D.E.
        • Cai S.
        • et al.
        Portal vein thrombosis and liver transplant survival benefit.
        Liver Transplant. 2010; 16: 999-1005
        • Rana A.
        • Hardy M.A.
        • Halazun K.J.
        • et al.
        Survival Outcomes Following Liver Transplantation (SOFT) Score: a novel method to predict patient survival following liver transplantation.
        Am J Transplant. 2008; 8: 2537-2546
        • Bonnet S.
        • Sauvanet A.
        • Bruno O.
        • et al.
        Long-term survival after portal vein arterialization for portal vein thrombosis in orthotopic liver transplantation.
        Gastroenterol Clin Biol. 2010; 34: 23-28
        • Norrby J.
        • Mjörnstedt L.
        • Liden H.
        • et al.
        Liver transplantation using cavoportal hemitransposition: a possibility in the presence of extensive portal vein thrombosis.
        Transplant Proc. 2001; 33: 2495-2496
        • Bertelli R.
        • Nardo B.
        • Montalti R.
        • et al.
        Liver transplantation in recipients with portal vein thrombosis: experience of a single transplant center.
        Transplant Proc. 2005; 37: 1119-1121
        • Dumortier J.
        • Czyglik O.
        • Poncet G.
        • et al.
        Eversion thrombectomy for portal vein thrombosis during liver transplantation.
        Am J Transplant. 2002; 2: 934-938
        • Manzanet G.
        • Sanjuán F.
        • Orbis P.
        • et al.
        Liver transplantation in patients with portal vein thrombosis.
        Liver Transplant. 2001; 7: 125-131
        • Thornburg B.
        • Desai K.
        • Hickey R.
        • et al.
        Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations.
        Tech Vasc Interv Radiol. 2016; 19: 52-60
        • Habib A.
        • Desai K.
        • Hickey R.
        • et al.
        Portal vein recanalization-transjugular intrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis.
        J Vasc Interv Radiol. 2015; 26: 499-506
        • Sabri S.S.
        • Caldwell S.H.
        • Kumer S.C.
        • et al.
        Combined transmesenteric and transhepatic recanalization of chronic portal and mesenteric vein occlusion to treat bleeding duodenal varices.
        J Vasc Interv Radiol. 2014; 25: 1295-1299
        • Matsui O.
        • Yoshikawa J.
        • Kadoya M.
        • et al.
        Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach.
        Cardiovasc Intervent Radiol. 1996; 19: 352-355
        • Farsad K.
        • Zaman A.
        Percutaneous transmesenteric portal vein recanalization and transjugular direct intrahepatic portosystemic shunt creation for chronic portal vein occlusion.
        J Vasc Interv Radiol. 2019; 30: 892-893
        • Entezari P.
        • Riaz A.
        • Thornburg B.
        • et al.
        Percutaneous ultrasound-guided superior and inferior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt: a case series.
        Cardiovasc Intervent Radiol. 2021; 44: 496-499
        • Thornburg B.
        • Desai K.
        • Hickey R.
        • et al.
        Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort.
        J Vasc Interv Radiol. 2017; 28: 1714-1721.e2
        • Hollingshead M.
        • Burke C.T.
        • Mauro M.A.
        • et al.
        Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis.
        J Vasc Interv Radiol. 2005; 16: 651-661
        • Liu F.-Y.
        • Wang M.-Q.
        • Fan Q.-S.
        • et al.
        Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis.
        World J Gastroenterol. 2009; 15: 5028-5034
        • Lopera J.E.
        • Correa G.
        • Brazzini A.
        • et al.
        Percutaneous transhepatic treatment of symptomatic mesenteric venous thrombosis.
        J Vasc Surg. 2002; 36: 1058-1061
        • Klinger C.
        • Riecken B.
        • Schmidt A.
        • et al.
        Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis.
        Dig Liver Dis. 2017; 49: 1345-1352
        • Wang M.Q.
        • Liu F.Y.
        • Duan F.
        • et al.
        Acute symptomatic mesenteric venous thrombosis: treatment by catheter-directed thrombolysis with transjugular intrahepatic route.
        Abdom Imaging. 2011; 36: 390-398
        • de Franchis R.
        • Bosch J.
        • Garcia-Tsao G.
        • et al.
        Baveno VII: renewing consensus in portal hypertension.
        J Hepatol. 2021; https://doi.org/10.1016/j.jhep.2021.12.022